Maarten Brom

Maarten Brom

A seasoned scientist, specialised in chemistry and nuclear imaging techniques. Maarten is a senior scientist with a focus on the development and characterization of radiolabeled and fluorescent tracers. He had various roles as a scientist at the Radboud Univeristy Medical Center in Nijmegen, The Netherlands, where his research in in vivo imaging techniques had a strong translational character.

Blog

What are radiopharmaceuticals? – Basics of nuclear medicine

Maarten Brom
Blog

SPECT vs PET in drug development

Maarten Brom
Blog

What are the 2 methods for labelling antibodies?

Maarten Brom
Blog

The preclinical work before your Phase 0 imaging study

Maarten Brom
Blog

Labeling of antibodies and antibody derivatives for molecular imaging

Maarten Brom
Blog

Why you don’t need imaging to apply microdosing

Maarten Brom
Blog

The value of Phase 0 imaging data to your IND application

Maarten Brom
Blog

How a Phase 0 imaging study can propel your radiopharmaceutical development

Maarten Brom
Blog

Does a Phase 0 study influence your Phase 1 trial?

Maarten Brom
Blog

Molecular imaging in anti-diabetic drug development

Maarten Brom
Blog

Why and how to standardize quantified PET scans in your trial

Maarten Brom
Blog

Molecular imaging of cancer vaccines

Maarten Brom
Blog

How your Phase 2 or 3 trial can benefit from molecular imaging

Maarten Brom
Blog

Who are involved in molecular imaging clinical trials?

Maarten Brom
Blog

Why you don’t need a GMP-compound to start your first-in-human study

Maarten Brom
Blog

Fast clinical translation of your therapeutic compound: A stepwise approach

Maarten Brom
Blog

What quality grade labeled compounds do you need in your trials?

Maarten Brom
Blog

What is the optimal label to trace your compound?

Maarten Brom
Blog

Types of nuclear medicine imaging techniques

Maarten Brom
Blog

Three Nuclear Imaging Strategies for Anti-inflammatory Drug Development

Maarten Brom
Blog

How to Use a Multimodal Imaging Approach in Clinical Trials

Maarten Brom
Blog

How to achieve a broad implementation of molecular imaging in drug development

Maarten Brom
Blog

How molecular imaging helps predict immunotherapy response

Maarten Brom